SRTS vs. TCMD, DCTH, ZIMV, CVRX, NPCE, SMTI, LUNG, DRTS, ELMD, and ZYXI
Should you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include Tactile Systems Technology (TCMD), Delcath Systems (DCTH), ZimVie (ZIMV), CVRx (CVRX), NeuroPace (NPCE), Sanara MedTech (SMTI), Pulmonx (LUNG), Alpha Tau Medical (DRTS), Electromed (ELMD), and Zynex (ZYXI). These companies are all part of the "medical equipment" industry.
Sensus Healthcare vs.
Tactile Systems Technology (NASDAQ:TCMD) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, community ranking, risk, valuation, profitability, institutional ownership and earnings.
In the previous week, Tactile Systems Technology had 2 more articles in the media than Sensus Healthcare. MarketBeat recorded 3 mentions for Tactile Systems Technology and 1 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 0.49 beat Tactile Systems Technology's score of 0.47 indicating that Sensus Healthcare is being referred to more favorably in the news media.
Tactile Systems Technology currently has a consensus target price of $23.00, suggesting a potential upside of 32.18%. Sensus Healthcare has a consensus target price of $12.50, suggesting a potential upside of 90.55%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Sensus Healthcare is more favorable than Tactile Systems Technology.
Tactile Systems Technology has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500.
Sensus Healthcare has a net margin of 22.54% compared to Tactile Systems Technology's net margin of 5.42%. Sensus Healthcare's return on equity of 17.99% beat Tactile Systems Technology's return on equity.
83.4% of Tactile Systems Technology shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 1.4% of Tactile Systems Technology shares are owned by insiders. Comparatively, 9.4% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Tactile Systems Technology has higher revenue and earnings than Sensus Healthcare. Sensus Healthcare is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.
Tactile Systems Technology received 195 more outperform votes than Sensus Healthcare when rated by MarketBeat users. Likewise, 70.20% of users gave Tactile Systems Technology an outperform vote while only 68.42% of users gave Sensus Healthcare an outperform vote.
Summary
Sensus Healthcare beats Tactile Systems Technology on 9 of the 17 factors compared between the two stocks.
Get Sensus Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sensus Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:SRTS) was last updated on 1/20/2025 by MarketBeat.com Staff
